 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
September 30, 2015 1:36 PM
|
SINGAPORE, Sept 28 — In the past, clinical research was sometimes done on researchers’ personal time — and even on their own dime — because of a shortage of resources, and getting published in | Read | Malay Mail Online...
|
|
Scooped by
Gilbert C FAURE
September 16, 2015 3:12 PM
|
by Yanhong Yuan, Xiajing Che, Zhaohui Ni, Yifei Zhong, Yinghui Qi, Xinghua Shao, Qin Wang, Liou Cao, Minfang Zhang, Yuanyuan Xie, Chaojun Qi, Lei Tian, Shan Mou Background and Objectives Renal relapse is a very common manifestation of IgA...
|
|
Scooped by
Gilbert C FAURE
July 24, 2015 9:45 AM
|
Journal of Human Genetics - Genome-wide association study of IgA nephropathy ...
Nature.com
Various mechanisms have been proposed for the characteristic IgA deposits in glomerular mesangial areas.
|
|
Scooped by
Gilbert C FAURE
June 14, 2015 1:45 PM
|
Nephrology (Carlton). 2015 Jun 7. doi: 10.1111/nep.12533. [Epub ahead of print]
|
|
Scooped by
Gilbert C FAURE
April 11, 2015 3:28 PM
|
Glomerular disease: Efficacy of corticosteroids in high-risk IgA nephropathy Nature.com Corticosteroids are frequently used to treat patients with IgA nephropathy (IgAN) despite a paucity of data to support their use in individuals with...
|
|
Scooped by
Gilbert C FAURE
February 15, 2015 2:53 PM
|
DEFA gene variants associated with IgA nephropathy in a Chinese population
Nature.com
IgA nephropathy (IgAN) is a complex syndrome with high genetic heterogeneity.
|
|
Scooped by
Gilbert C FAURE
February 1, 2015 1:23 PM
|
by Yifei Zhong, Ke Wang, Xianwen Zhang, Xiaofan Cai, Yiping Chen, Yueyi Deng
Nephrokeli (NPKL) is a Chinese herbal formula that has been used to treat patients with IgA nephropathy (IgAN) for improvement of proteinuria and kidney injury.
|
|
Scooped by
Gilbert C FAURE
December 13, 2014 2:51 PM
|
Lettuce is a kind of popular and healthy green vegetable packed with essential nutrients. Is lettuce good for IgA Nephropathy patients? As we all know, IgA Neph
|
|
Scooped by
Gilbert C FAURE
October 19, 2014 2:56 PM
|
Have you read about our latest research into IgA Nephropathy? Read more: http://t.co/WROygMO12b #kidneydisease #kidney
|
|
Scooped by
Gilbert C FAURE
June 12, 2014 6:03 AM
|
by Kazuo Takahashi, Milan Raska, Milada Stuchlova Horynova, Stacy D. Hall, Knud Poulsen, Mogens Kilian, Yoshiyuki Hiki, Yukio Yuzawa, Zina Moldoveanu, Bruce A. Julian, Matthew B.
|
|
Scooped by
Gilbert C FAURE
April 25, 2014 1:43 PM
|
Transplant Outcomes Better in IgA Nephropathy Patients Renal and Urology News Aditya Kadiyala, MD, of Hofstra-North Shore Long Island Jewish Health System in Great Neck, NY, and colleagues analyzed data from 98,450 adult first-time kidney...
|
|
Scooped by
Gilbert C FAURE
November 24, 2013 11:59 AM
|
WIPO patent: Provided is a novel method for detecting IgA nephropathy using a lectin having binding specificity to a structure characteristic of an IgA aggregate that is observed in an IgA nephropathy patient.
|
|
Scooped by
Gilbert C FAURE
June 24, 2013 1:03 PM
|
Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA ...
PR Newswire (press release)
In May, the company met with the US FDA to discuss the future of the IgA nephropathy development plan.
|
|
|
Scooped by
Gilbert C FAURE
September 26, 2015 5:22 AM
|
by Shui-Ming Guo, Min Han, Mei-Xue Chen, Yong Ning, Guang-Chang Pei, Yue-Qiang Li, Wei Dai, Shu-Wang Ge, Yuan-Jun Deng, Yan-Yan Guo, Xiao-Qing Li, Hermann Haller, Gang Xu, Song Rong Background Soluble urokinase receptor (suPAR) may be involved in...
|
|
Scooped by
Gilbert C FAURE
July 28, 2015 8:23 AM
|
"A new monoclonal antibody for detecting degalactosylated IgA1 as serum biomarker of IgA nephropathy" #nephrology http://t.co/FRVdvzuGgj
|
Suggested by
Société Francaise d'Immunologie
July 23, 2015 8:53 AM
|
Cell Physiol Biochem. 2015 Jul 13;36(5):1793-1808. [Epub ahead of print]
|
|
Scooped by
Gilbert C FAURE
April 20, 2015 1:55 PM
|
Pharmalink AB, a specialty pharma company, today announces that the NEFIGAN Trial of Nefecon for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis and been stopped early with respect...
|
|
Scooped by
Gilbert C FAURE
March 13, 2015 3:26 PM
|
Corticosteroid treatment decreased proteinuria and the rate of renal function decline and increased renal survival, study finds.
|
|
Scooped by
Gilbert C FAURE
February 4, 2015 1:33 PM
|
by Qiang Sun, Jianqian Zhang, Nan Zhou, Xiaorong Liu, Ying Shen
IgA nephropathy (IgAN) is one of the most common glomerular diseases leading to end-stage renal failure. Elevation of aberrantly glycosylated IgA1 is a key feature of it.
|
|
Scooped by
Gilbert C FAURE
January 30, 2015 2:22 PM
|
Sweden-based specialty pharma company Pharmalink has announced that its investigational new drug (IND) application for Nefecon is now open with the US
|
|
Scooped by
Gilbert C FAURE
October 20, 2014 5:03 AM
|
PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
|
Scooped by
Gilbert C FAURE
August 19, 2014 4:51 AM
|
by Jeffrey B. Hodgin, Celine C. Berthier, Rohan John, Elisabeth Grone, Stefan Porubsky, Hermann-Josef Gröne, Andrew M. Herzenberg, James W. Scholey, Michelle Hladunewich, Daniel C. Cattran, Matthias Kretzler, Heather N.
|
|
Scooped by
Gilbert C FAURE
June 4, 2014 1:45 PM
|
IgA nephropathy (IgAN) represents the leading cause of kidney failure among East Asian populations and the most frequent form of primary glomerulonephritis among Europeans. Patients with IgAN develop characteristic ...
|
|
Scooped by
Gilbert C FAURE
April 11, 2014 5:22 AM
|
IgA Nephropathy is an autoimmune disorder that occurs when IgA settles in kidneys. If we want to know causes of IgA Nephropathy, we need to know what IgA is and how it affects kidney.
|
|
Scooped by
Gilbert C FAURE
June 25, 2013 1:31 PM
|
Anthera commences Phase 2 study of IgA nephropathy therapy
Pharmaceutical Business Review
Anthera Pharmaceuticals has begun the BRIGHT-SC Phase 2 IgA nephropathy study of an inhibitor of B-Cell Activating Factor (BAFF), blisibimod.
|
Scoop.it!
IgA nephropathy inside
published online